Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 17,501 |
| Marketable Securities | 0 | 0 | 0 | 7,386 |
| Other current assets | 0 | 0 | 0 | 519 |
| TOTAL | $0 | $0 | $0 | $25,406 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 133 |
| Other Non-Current Assets | 0 | 0 | 0 | 20 |
| TOTAL | $N/A | $N/A | $N/A | $153 |
| Total Assets | $0 | $0 | $0 | $25,505 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 542 |
| Accrued Expenses | 0 | 0 | 0 | 2,397 |
| TOTAL | $0 | $0 | $0 | $2,939 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $41 |
| Total Liabilities | $0 | $0 | $0 | $2,980 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | 0 | -25,493 |
| Other shareholders' equity | 0 | 0 | 0 | 45,655 |
| TOTAL | $0 | $0 | $0 | $22,525 |
| Total Liabilities And Equity | $0 | $0 | $0 | $25,505 |